{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["36(1)"],"submitter":["Urbanczyk JP"],"pubmed_abstract":["Ventricular septal defect (VSD) rarely occurs following transcatheter aortic valve implantation (TAVI). We report two patients who developed VSD following TAVI. One case was a Gerbode defect treated by percutaneous closure, and the second was a restrictive perimembranous VSD managed conservatively."],"journal":["Proceedings (Baylor University. Medical Center)"],"pagination":["106-108"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9762799"],"repository":["biostudies-literature"],"pubmed_title":["Iatrogenic ventricular septal defects following transcatheter aortic valve implantation."],"pmcid":["PMC9762799"],"pubmed_authors":["Konda S","Caldera AE","Urbanczyk JP","Mixon TA"],"additional_accession":[]},"is_claimable":false,"name":"Iatrogenic ventricular septal defects following transcatheter aortic valve implantation.","description":"Ventricular septal defect (VSD) rarely occurs following transcatheter aortic valve implantation (TAVI). We report two patients who developed VSD following TAVI. One case was a Gerbode defect treated by percutaneous closure, and the second was a restrictive perimembranous VSD managed conservatively.","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-18T13:09:07.865Z","creation":"2025-04-06T22:40:39.639Z"},"accession":"S-EPMC9762799","cross_references":{"pubmed":["36578605"],"doi":["10.1080/08998280.2022.2119543"]}}